Pediatric cancer drug shows 93 percent response rate

(UT Southwestern Medical Center) A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested, researchers at UT Southwestern's Simmons Cancer Center announced.